USING ULTRASOUND STUDIES TO ASSESS OBESITY AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE
Creators
- 1. teachers of technical school of public health named after Abu Ali ibn Sino
- 2. students of the Samarkand State Medical University
Description
For many decades' obesity has been one of the main risk factors for the development of cardiovascular pathology. Despite the work of scientists and doctors of various specialities, the burden of this pathology continues to increase its contribution to morbidity and mortality from cardiovascular diseases. Numerous anthropometric criteria of obesity are well studied, simple and inexpensive means of diagnosing overweight in the population. However, their accuracy is relatively low. In particular, body composition, which is key to cardiovascular risk stratification, cannot be determined using these criteria. Despite the relatively short period of use of ultrasound methods for the diagnosis of obesity, convincing evidence of their high accuracy and effectiveness in predicting cardiovascular risk has already been obtained. Given the continuous improvement of ultrasound machines, the criteria considered should be incorporated into routine clinical and research practice.
This literature review considers the main parameters used in ultrasound diagnosis of obesity, their contribution to the development of both traditional risk factors and directly cardiovascular diseases.
Files
356-362 Xakimova Shaxlo Islomovna.pdf
Files
(1.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:7b7bdc12050fd65130c4838e3d357552
|
1.8 MB | Preview Download |
Additional details
References
- 1. Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular disease. Int J Cardiol. 2019;278:254-60. doi:10.1016/j.ijcard.2018.09.089.
- 2. Bays H., Gomzalez-Campoy J., Henry Bays K. Is adiposopathy (sick fat) an endocrine disease? Complitation Int Illin Pract. 2008; 62 (10): 1474-1483.
- 3. Bazzocchi A, Filonzi G, Ponti F, et al. The role of ultrasonography in the evaluation of abdominal fat: analysis of technical and methodological issues. Acad Radiol. 2013;20:1278-85. doi:10.1016/j.acra.2013.07.009.
- 4. Bazzocchi A, Ponti F, Diano D, et al. Abdominal adiposity by ultrasonography: a "pocket" database for reference standard in Italian people. Prim Care Diabetes. 2014;8:358-64. doi:10.1016/j.pcd.2014.02.003.
- 5. Bertoli S, Leone A, Vignati L, et al. Metabolic correlates of subcutaneous and visceral abdominal fat measured by ultrasonography: a comparison with waist circumference. Nutr J. 2016;15:2. doi:10.1186/s12937-015-0120-2.
- 6. Buhr M., Bocker K., Manns M. et al. Decreased hepatic KBP4 secretion is correlated with reduced hepatic glucose production but is not-associated with insulin resistance in patients with liver cirrhosis // J. Clin. Clin. Endocrinol. - 2009; 70 (1): 152-161.
- 7. Chazova I.E., Mychka V.B. Metabolic syndrome // Consilium medicum. - 2002; 4: 11: 557-592.
- 8. Dedov I.I., Melnichenko G.A., Romantsova T.I. Pathogenetic aspects of obesity // Obesity and Metabolism. - 2004; 1: 3-9.
- 9. Despres J.-P., Poirier P., Bergeron J. et al. From individual risk factors and the metabolic syndrome to global cardiometabolic risk // Eur. Heart. J. - 2008; 10 (suppl B): 24-33.
- 10. Hiremath R, Ibrahim J, Prasanthi K, et al. Comparative study of ultrasonographic and anthropometric measurements of regional adiposity in metabolic syndrome. J Clin Diagn Res. 2017;11(8):TC01-TC05. doi:10.7860/JCDR/2017/26386.10352.